Question & AnswerQ&A (PHIC PHILHEALTH CIRCULAR NO.08, S.2005)
The circular is titled PHIC PHILHEALTH CIRCULAR NO.08, S.2005 dated February 21, 2005.
The circular covers Sections 9.0 (Antineoplastics and Immunosuppressants), 10.0 (Drugs Affecting the Blood), 11.0 (Blood Products and Blood Substitutes), and 12.0 (Antidotes).
The latest edition was approved by the Secretary of Health.
Section 37 of Republic Act 7875 mandates the use of the latest edition of the PNDF for reimbursement.
Claims with discharge dates starting March 1, 2005, are compensable for newly listed drugs and preparations in those sections.
Denial of PhilHealth coverage or reimbursement for delisted drugs will be held in abeyance pending completion of the entire PNDF list or provision of reasons for their deletion by the National Formulary Committee.
All other issuances inconsistent with this circular are repealed and modified accordingly.
The circular was signed by Francisco T. Duque III, MD, MSc.
The text of the annexes is available at the Office of the National Administrative Register, U.P. Law Complex, Diliman, Quezon City.
The National Formulary Committee is responsible for approving the list of drugs in the PNDF and providing reasons for any deletion of drugs listed in the formulary.